Table 2.
Number of retinal ganglion cells per region of interest in the normal and ischemic retinae 7 days after ischemia+Post-C for all the siRNA treatments
| Normal retina | Ischemic retina | p value | |
|---|---|---|---|
| Non-silencing siRNA/post-conditioning | 10.4±0.9 | 9.8±0.9 | 0.40 |
| p38α siRNA/post-conditioning | 11.8±0.6 | 7.9±0.8 | 0.03 |
| Akt1 siRNA/post-conditioning | 11.6±0.4 | 6.7±0.5 | 0.03 |
| Akt2 siRNA/post-conditioning | 11.3 ±0.9 | 7.9±0.9 | 0.04 |
| Akt3 siRNA/post-conditioning | 10.6±0.2 | 7.1±0.4 | 0.07 |
Post-conditioning (top row) prevented the loss of retinal ganglion cells; this effect was attenuated by p38α, Akt1, and Akt2 siRNA. Akt3 siRNA caused a decrease that was not significant. Statistical analysis was achieved using the non-parametric Wilcoxon test